Catch up on the essentials
- Lam Research reported first-quarter fiscal 2027 revenue of $8.22 billion and net income of $2.75 billion.
- Management described component shortages as an ongoing operational constraint and said it expected China-related revenue to decline in the near term, with a sharp drop indicated for the December quarter.
- Investors can compare reported revenue and net income per diluted share with the guidance ranges and assess whether component constraints or weaker China-related revenue affect shipments as expected.
Selected from this article · 2026-11-04
Read on for the full pictureLam Research reports record fiscal 2027 results

Lam Research reported first-quarter fiscal 2027 revenue of $8.22 billion and net income of $2.75 billion. Diluted earnings per share from continuing operations were $2.19, according to the company results reported by Simply Wall St and Yahoo! Finance Canada.
The results were paired with December-quarter guidance that included revenue of $8.6 billion plus or minus $400 million and net income per diluted share of $2.33 plus or minus $0.15. The guidance is forward-looking and remains subject to component shortages, export controls and changes in China-related revenue.
Component shortages and China exposure constrain the outlook
Management described component shortages as an ongoing operational constraint and said it expected China-related revenue to decline in the near term, with a sharp drop indicated for the December quarter. The reports said the company’s ability to convert strong demand into shipments would depend on supply continuity while regional demand and customer timing remained uncertain.
The December guidance therefore provides a reference point for execution, including whether delayed tools can move into later quarters and whether lower China contribution can be offset by activity in the United States, Korea, Taiwan and other regions. These were analytical monitoring points in the reports, not confirmed customer orders or additional guidance.
Longer-range estimates remain subject to export-control and timing risks
Both reports described Lam Research’s investment case as tied to the wafer fabrication equipment cycle, including AI infrastructure, new Tier 1 fabs and more complex chip architectures. Management was reported to expect wafer fabrication equipment spending to exceed $200 billion in 2027, with gate-all-around transistors, EUV lithography, backside power delivery and advanced packaging identified as important drivers.
Analyst consensus cited in the reports pointed to $49.9 billion of revenue and $18.5 billion of earnings by 2029, based on assumed annual revenue growth of 24.1% and an earnings increase of about $10.1 billion from the then-current $8.4 billion earnings figure. More cautious forecasts modeled approximately $46.5 billion of revenue and $16.6 billion of earnings by 2029, reflecting greater export-control risk, while more optimistic projections were also cited.
The next operating checkpoint is December-quarter execution
The principal measurable checkpoint in the reviewed reporting is Lam Research’s December 2026 quarter. Investors can compare reported revenue and net income per diluted share with the guidance ranges and assess whether component constraints or weaker China-related revenue affect shipments as expected. The reports also noted that investors backed proposals at the shareholder meeting, including the election of 10 directors and ratification of KPMG for fiscal 2027.
Share this article

